The following bills are scheduled for hearing in the Banking, Commerce and Insurance Committee on February 27: 

  • LB 990: legislation banning PBMs from restricting an enrollee’s ability to choose how a retail community pharmacy may dispense or deliver prescription drugs and clarifies that “reasonable terms” between PBMs and specialty pharmacies cannot exceed reporting requirements and performance requirements that are required for a nationally recognized independent accrediting organization among its various provisions. 
  • LB 1232: legislation banning PBMs from reimbursing pharmacists or pharmacies for a drug at a lower rate than the cost required to dispense the drug. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.